Choice behavior and approach–avoidance model fits for mixed and loss trials. A, Mixed gamble value was determined by the ratio of the potential gain to the potential loss. As mixed gamble value increased, subjects gambled more, as expected. B, Average model fit across subjects for the approach–avoidance model. C, Subjects who received higher effective doses did not have a larger change in the number of mixed gambles chosen on l-DOPA than placebo (Spearman's ρ = 0.02, p = 0.91), a relationship that would be negative if l-DOPA decreased risk taking. D, Loss gamble value was determined relative to the value of the certain option. As loss gamble value increased, subjects gambled more, as expected. E, Average model fit across subjects for the approach–avoidance model, which can account for the low probability of gambling for even the highest gamble values in placebo and l-DOPA sessions. F, Subjects who received higher effective doses did not have a larger change in the number of loss gambles chosen on l-DOPA than placebo (Spearman's ρ = 0.19, p = 0.32), a relationship that would be negative if l-DOPA decreased risk taking.